<DOC>
	<DOCNO>NCT02116452</DOCNO>
	<brief_summary>The study objective evaluate whether specific prebiotic ( GOS/PDX ) may effect prevent atopic dermatitis , food allergy , intestinal and/or respiratory infection infant risk atopy . In infant dermatitis , hypothesis test prebiotics reduce severity disease .</brief_summary>
	<brief_title>Prebiotics Prevention Atopy</brief_title>
	<detailed_description>This study prospective , double blind , randomise , 24 month study trial compare formula 50/50 mixture GOS/PDX ( Enfamil Premium Infant Formula 1 child &lt; 6 month Formula 2 child ≥ 6 month ) versus standard formula ( Enfamil Premium Formula 1 2 ) . Study population compose newborn risk allergy identify time delivery . Infants eligible least one parent one old sibling physician-diagnosed atopic disease ( asthma , allergic rhinoconjunctivitis , atopic dermatitis , allergic urticaria , food allergy follow describe . At time enrolment ( within first 4 week life ) infant randomise 1:1 receive start formula feed day 6th month birthday .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>1 . Gestational age &gt; 37 &lt; 42 week . 2 . Birth weight &gt; 2500 gr . 3 . At risk atopy ( see appendix 1 ) . 4 . Informed consent sign parent ( see appendix 3 ) . 1 . Congenital immunodeficiency 2 . Severe congenital disorder malformation 3 . Born mother diabet 4 . Long term intake ( &gt; 7 consecutive day ) pro prebiotics 5 . Children already assume ≥ 50 mL feed bottle Formulas different one object study month . 6 . Parents expect compliant study procedure</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Weeks</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>